Literature DB >> 30064724

Complications, length of stay, and cost of cholecystectomy in kidney transplant recipients.

Sandra R DiBrito1, Christine E Haugen2, Courtenay M Holscher3, Israel O Olorundare4, Yewande Alimi5, Dorry L Segev6, Jacqueline Garonzik-Wang7.   

Abstract

We hypothesized that cholecystectomy may be riskier for kidney transplant recipients (KTR) given their lifelong immunosuppression, physiologic impact of renal failure, and increased risk of gallstone and biliary disease. Using NIS, we compared mortality, morbidity, length of stay and cost in KTR vs non-KTR following cholecystectomy in the US from 2000 to 2011, adjusting for patient and hospital level factors, including transplant center status. Mortality was higher (OR 2.4), morbidity was higher (OR 1.3), LOS was longer (ratio 1.2), and costs were greater (ratio 1.1) for KTR compared to non-KTR following cholecystectomy. While it is clear that KTR are a high risk group following cholecystectomy, the cause of this increased risk requires further investigation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholecystectomy; General surgery; Kidney transplantation

Mesh:

Year:  2018        PMID: 30064724      PMCID: PMC6177305          DOI: 10.1016/j.amjsurg.2018.07.023

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  26 in total

1.  Laparoscopic cholecystectomy for renal transplants.

Authors:  O Banli; N Guvence; H Altun
Journal:  Transplant Proc       Date:  2005-06       Impact factor: 1.066

Review 2.  Perioperative concerns for transplant recipients undergoing nontransplant surgery.

Authors:  James Whiting
Journal:  Surg Clin North Am       Date:  2006-10       Impact factor: 2.741

3.  Complications of gallstone disease in kidney transplantation patients.

Authors:  S Sarkio; K Salmela; L Kyllönen; M Rosliakova; E Honkanen; L Halme
Journal:  Nephrol Dial Transplant       Date:  2007-01-05       Impact factor: 5.992

4.  The transplant center and business unit as a model for specialized care delivery.

Authors:  A Osama Gaber; Roberta L Schwartz; David P Bernard; Susan Zylicz
Journal:  Surg Clin North Am       Date:  2013-12       Impact factor: 2.741

5.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

6.  A current profile and assessment of north american cholecystectomy: results from the american college of surgeons national surgical quality improvement program.

Authors:  Angela M Ingraham; Mark E Cohen; Clifford Y Ko; Bruce Lee Hall
Journal:  J Am Coll Surg       Date:  2010-08       Impact factor: 6.113

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients.

Authors:  J Alberú; M Gatica; M Cachafeiro-Vilar; G Robles-Díaz; P Bezaury; F Paz-Pinedo; F Vargas-Vorácková
Journal:  Rev Invest Clin       Date:  2001 Sep-Oct       Impact factor: 1.451

9.  Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.

Authors:  M Bernabeu-Wittel; M Naranjo; J M Cisneros; E Cañas; M A Gentil; G Algarra; P Pereira; F J González-Roncero; A de Alarcón; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-03-19       Impact factor: 3.267

10.  An audit of laparoscopic cholecystectomy in renal transplant patients.

Authors:  Vk Sutariya; Ah Tank
Journal:  Ann Med Health Sci Res       Date:  2014-01
View more
  1 in total

1.  Acute Care Surgery for Transplant Recipients: A National Survey of Surgeon Perspectives and Practices.

Authors:  Sandra R DiBrito; Mary Grace Bowring; Courtenay M Holscher; Christine E Haugen; Sarah V Rasmussen; Mark D Duncan; David T Efron; Kent Stevens; Dorry L Segev; Jacqueline Garonzik-Wang; Elliott R Haut
Journal:  J Surg Res       Date:  2019-06-03       Impact factor: 2.192

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.